Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin D and systemic therapy.

Peter van de Kerkhof1

  • 1Department of Dermatology, University Hospital, Nijmegen, Netherlands.

Cutis
|December 7, 2002
PubMed
Summary
This summary is machine-generated.

Topical calcipotriene combined with systemic psoriasis treatments like methotrexate, oral retinoids, and cyclosporine enhances efficacy and reduces side effects. This combination therapy offers a safer and more effective approach for severe psoriasis management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to Woodie et al, "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX".

Journal of the American Academy of Dermatology·2026
Same author

Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Mortality, prevalence, comorbidity, and flare patterns in generalised pustular psoriasis: a comprehensive literature review.

European journal of dermatology : EJD·2026
Same author

Psoriasis treatment training in dermatology residency: a Latin American survey of faculty and residents.

The Journal of dermatological treatment·2025
Same author

The Burden of Pediatric Psoriasis: A Systematic Review.

American journal of clinical dermatology·2025
Same author

Comments on Consensus for Generalized Pustular Psoriasis-Reply.

JAMA dermatology·2025
Same journal

Black Dots on the Scalp of a Child.

Cutis·2026
Same journal

Psoriasis and Obesity: A Clinical Review of the Bidirectional Link and Management Implications.

Cutis·2026
Same journal

Adalimumab in Lichen Planus: A Narrative Review of Treatment and Paradoxical Reactions.

Cutis·2026
Same journal

The Future of Psoriasis Care.

Cutis·2026
Same journal

Evaluating GPT-4o for Automated Classification of Skin Lesions Using the HAM10000 Dataset.

Cutis·2026
Same journal

Metastatic Primary Extramammary Paget Disease: A Case Series.

Cutis·2026
See all related articles

Area of Science:

  • Dermatology
  • Pharmacology
  • Immunology

Background:

  • Severe psoriasis often requires systemic treatments such as methotrexate (MTX), oral retinoids, and cyclosporine.
  • These systemic agents carry dose-related toxicities, limiting their long-term use and patient adherence.
  • Topical calcipotriene has established safety and efficacy in psoriasis treatment.

Purpose of the Study:

  • To evaluate the therapeutic benefit of combining topical calcipotriene with systemic antipsoriatic agents.
  • To assess if combination therapy improves efficacy and reduces the toxicity profile of systemic treatments for severe psoriasis.

Main Methods:

  • Conducted three controlled clinical trials.
  • Investigated the addition of calcipotriene ointment to systemic therapies (methotrexate, acitretin, cyclosporine).

Related Experiment Videos

  • Compared outcomes against systemic therapy administered alone.

    • Main Results:

    • Combination therapy significantly increased therapeutic efficacy compared to systemic treatment alone.
    • The addition of calcipotriene helped minimize side effects.
    • Side effect reduction was achieved by lowering the dosage or duration of systemic agents.

    Conclusions:

    • Combining topical calcipotriene with systemic treatments (methotrexate, oral retinoids, cyclosporine) is an effective strategy for severe psoriasis.
    • This approach enhances treatment efficacy while mitigating the dose-related toxicities associated with systemic agents.
    • Calcipotriene combination therapy offers a safer and potentially more tolerable treatment option for patients with severe psoriasis.